➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Dow
Boehringer Ingelheim
Express Scripts
Colorcon

Last Updated: August 6, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for L-Leucine

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug L-Leucine?

L-Leucine is an investigational drug.

There have been 27 clinical trials for L-Leucine. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2001.

The most common disease conditions in clinical trials are Neuroblastoma, Ganglioneuroblastoma, and Anemia. The leading clinical trial sponsors are National Cancer Institute (NCI), Roswell Park Cancer Institute, and IntraBio Inc.

Recent Clinical Trials for L-Leucine
TitleSponsorPhase
Treatment With Dinutuximab in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk NeuroblastomaNational Cancer Institute (NCI)Phase 2
Treatment With Dinutuximab in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk NeuroblastomaChildren's Oncology GroupPhase 2
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory NeuroblastomaNational Cancer Institute (NCI)Phase 2

See all L-Leucine clinical trials

Clinical Trial Summary for L-Leucine

Top disease conditions for L-Leucine
Top clinical trial sponsors for L-Leucine

See all L-Leucine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Dow
Boehringer Ingelheim
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.